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Acute lung injury (ALI) and its severe form, acute respiratory distress
syndrome (ARDS), are lung pathologies that confer considerable morbidity
and high mortality. They usually occur short after an ordinary injury (e.g.
trauma, burns, aspiration) or an acute illness (e.g. pneumonia, acute pan-
creatitis).
Acute lung injury has no specic treatment but it is common practice to
treat it with mechanical ventilation in supportive care in order to reduce air-
way pressure while maintaining adequate oxygenation. Ventilation is usually
provided through oro-tracheal tube or tracheostomy.
Studies hve demonstrated that one cause of ALI exacerbation to ARDS
can be the mechanical ventilation provided in the intensive care unit ICU
because high airway pressures applied to both healthy and injured lungs can
aggravate in
ammation by promoting alveolar distention. The physiological
processes that are behind this evolution are not completely clear. Probably
they are correlated to polymorphonuclear neutrophils (PMNs) activation,
that is the mainstay of in
ammation. However the uncertainty about the
dynamic of the system justies an onward interest in studying lung in
am-
mation.
Positron Emission Tomography (PET) with [18F]-
uoro-2-deoxy-D-glucose
(FDG) tracer is a nuclear medicine imaging technique that produces three-
dimensional pictures of the functional processes of the model related to tis-
sue metabolic activity. The data resulting from FDG-PET studies in vivo
are already widely used to extract quantitative and qualitatively clinical in-
formation like the metabolic rate, the blood 
ow in the brain, the receptor
anity of drugs in cerebral structures, etc. Since neutrophils activation is
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associated to an increase in cellular metabolism, FDG-PET studies could be
suitable to describe the dynamic of lung in
ammation.
In this work we performed FDG-PET studies on a dataset composed by 17
subjects with the aim of quantifying the dynamic of the glucose metabolism
in healthy and injured lung tissues. Twelve subjects were patients aected
by a severe form of ALI undergoing mechanical ventilation. Five subjects
were healthy volunteer, whose studies were used as control.
Image pre-processing of the data was necessary in order to distinguish the
lung from the other tissues present in the thoracic area, to dene the regions
of interest (ROIs) and to reconstruct the arterial input function. These oper-
ations were performed using both PET and CT data. The graphical method
(Patlak plot) and the data-driven methods (spectral analysis and spectral
analysis iterative lter) were then applied to quantify glucose metabolism.
Analyses were carried out at both ROI and voxel level. With this double
level analysis it has been possible to consider the presence of heterogeneity
in the lung tissues. The results of quantication suggested that the presence
of in
ammation in the lung tissues greatly aects the metabolism of glucose
compared to the healthy subjects. Moreover the application of the FDG-
PET method allowed a better classication of the level of in
ammation in
injured lungs than the standard approach based on CT. Even though more
studies are still necessary to dene a full-model of the glucose metabolism
system in lungs; the application of Spectral Analysis methodologies gave im-
portant indications about the number of compartments necessary to describe
the data at both ROI and voxel level.Chapter 1
Clinical Overview
1.1 Positron Emission Tomography
Positron emission tomography (PET) has made it possible to detect ac-
curately and noninvasively at the regional level (i.e., organ and tissue) the
concentration of radiopharmaceuticals tagged with positron emitters. Image
analysis can be made both qualitatively and quantitatively. For some clinical
PET studies, a qualitative analysis is appropriate to answer biological ques-
tions, such as when the localization of metabolic defects is the principal pur-
pose of the study. However, quantitative information is often necessary, and
this requires interpretation of the PET tracer measurement with a mathe-
matical model of the underlying physiological process. PET kinetic modeling
allows, for example, the estimation of the glucose metabolic rate and blood

ow in the brain (Phelps 1979; Iida 1986), in the skeletal muscle (Kelley
1999a; Kelley 1996; Ruotsalainen 1997), and in myocardium (Gambhir 1989;
Bergman 1984), as well as estimation of receptor anity in specic cerebral
structures (Wong 1986). Recently it has been used also for lung regional
metabolic activity quantication during in
ammation (Schroeder 2008; Bel-
lani 2009) to enable a better understanding of in
ammatory processes at all
stages of disease.[5]
34 CHAPTER 1. CLINICAL OVERVIEW
1.1.1 Principles
Positron Emission Tomography is a nuclear imaging modality that excels
in depicting the biology of living tissue and that enables regional function to
be assayed in a fully quantitative and noninvasive manner. While the res-
olution of magnetic resonance imaging (MRI) for structural tissue changes
is unsurpassed, the ability of structural MRI to demonstrate alterations in
the physiology and metabolic function of tissues remains poor. For this rea-
son, combining the functional PET data with the high-resolution anatomical
maps produced by MRI provides powerful data sets which allow correspon-
dences to be identied and analyze in a better way the dierent structures
[4]. This combination of techniques is recommended especially for the brain,
as in our study, since it is a complex neuronal network in which all sub-
units can communicate directly or indirectly with each other. This nuclear
technique involves the introduction, usually via an intravenous injection, of
a radioactive tracer into the human body; they are prepared in a cyclotron
that accelerates a beam of protons and directs it towards the target nu-
clei, thereby incorporating an extra proton into them: this generates new
compounds that are energetically unstable. The isotopes are then coupled
to the compound of interest and that is the tracer. Since they are unsta-
ble, the isotopes undergo a process of decay whereby the excess proton is
converted into a neutron, a positron, and a neutrino: the emitted positron
travels up to a range of a few millimeters in tissue before annihilates with
an electron [15] (Figure 1.1.1(a)). This mutual annihilation process pro-
duces two 511 keV rays going in opposite directions (they are released at
180) and which are detected by the several rings of PET scanner. This con-
sists of circumferential arrays of detectors which look for coincidence events,
in which two ray interaction occur almost simultaneously on opposite side
of the head (Figure 1.1.1(b)). Finally, through reconstruction software the
tomographic image is obtained: the count density in the resulting images,
assuming appropriate data corrections are applied, re
ects the concentration
of the positron-emitting isotope in the tissue. The main characteristics that
make PET a charming technique in the neuroimaging eld are superior sensi-1.1. POSITRON EMISSION TOMOGRAPHY 5
tivity, high quantity of information and a greater 
exibility of incorporating
positron labels into biomolecules. On the other side, the main disadvantage
of PET is greater expense in comparison with other techniques.
(a) Positron emission and annihilation
(b) Schematic representation of detectors in PET
Figure 1.1: The main principles of PET imaging.6 CHAPTER 1. CLINICAL OVERVIEW
1.1.2 Tracers
A tracer is an indicator molecule that follows a systemic substance that
might be involved in 
ow, metabolism or drug-binding process and that is
labelled with a positron{emitting isotope. It should be analogous to the
systemic substance and does not perturb the system. Availability of car-
bon, oxygen and nitrogen isotopes makes easy to study biological processes
with PET because these are elements present in almost all organic molecules.
Isotope Half-Live Tracer Parameters
Nitrogen-13 13N 9.8 min Ammonia Coronary 
ow
Carbon-11 11C 20.4 min Palmitate Fatty acid metabolism
Acetate Oxygen consumption
Fluorine-18 18F 109.8 min Fludeoxyglucose Glucose metabolism
Oxygen-15 15O 2.07 min Water Local 
uxes
Carbon dioxide Local 
uxes
Carbon monoxide Blood volume
Rubidium 82 82Rb 4.58 hours Rubidium Miocardic perfusion
Table 1.1: Labelled molecules used in PET tracers.
Looking at the table, it is noticeable the relatively short half-lives of
tracers. This implies two advantages. First, it is possible to employ high
radioactivity, that results in a quite accurate measurement without exposing
the subjects to prolonged periods of radiation; second, several studies on the
same patient are possible in a reasonable time interval.[6]
1.2 Lung disease
1.2.1 Denition and Histopathology
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)
are characterized by the abrupt onset of clinically signicant respiratory fail-
ure with presence of diuse pulmonary inltrates. They are shown on ra-
diograph as pulmonary edema resulting from increased pulmonary vascular1.2. LUNG DISEASE 7
permeability, with alveolar 
ooding and loss of compliance. Both patholo-
gies can be the consequence of pulmonary or extra pulmonary insults but the
likelihood of developing depends on the predisposing disorder, some events
are more likely to progress to lung injury than others. The pulmonary in-

ammation response is a complex process involving a number of dierent cell
types some of which, that usually play an important role in counter infection
and heal lung tissue, may be themselves partially responsible for the patho-
genesis of chronic lung disease that leads to irreversible lung damage and loss
of function.
ALI is characterized by hypoxaemia (PaO2/FiO2 ratio < 300 mm Hg) 1
without an excessive increase in pulmonary capillary pressure; when the hy-
poxaemia is severe (PaO2/FiO2 < 200 mm Hg ) disorder is termed as acute
respiratory distress syndrome (ARDS). However, most epidemiological and
interventional studies use the broader range of gas exchange abnormality and
refer to the overall disorder as acute lung injury; these denitions have lim-
itations due to variability of several physiological parameters. Hypoxaemia
is a clinically manifestation of the early phase of in
ammation where leak-
age of edema 
uid into the lung and in
ammatory cellular inltration cause
diusion abnormalities and ventilation perfusion mismatch.[8]
Increased alveolar capillary membrane permeability is a central feature
of the acute phase of ALI and ARDS. It is associated with diuse alveo-
lar damage, which includes alveolar 
ooding, inltration by neutrophils and
macrophages, and formation of hyaline membranes.
Early acute lung injury is histologically characterized by a diuse neu-
trophilic alveolar inltrate and the accumulation of a protein-rich pulmonary
edema. During this acute phase, cytokines incite and perpetuate in
amma-
tion. By increasing oxidant stress and protease activity, the in
ammatory
mixture in the alveoli and interstitium reduces surfactant production, and
inactivates remaining surfactant, thereby promoting widespread atelectasis.
Additionally, there is a damage of the structural framework of the lung, and
both alveolar capillary and epithelial-cell injury can be seen. Damage of
1PaO2 is the partial pressure of oxygen while FiO2 is the fraction of inspired oxygen.
Ratio indicates the eectiveness of oxygen transition through alveolus-capillary membrane8 CHAPTER 1. CLINICAL OVERVIEW
Figure 1.2: Normal and in
amed alveolus.
the epithelial barrier exacerbates the tendency for alveolar 
ooding, and de-
lays recovery by impairing 
uid clearance. The in
ammatory process can
evolve to a subacute phase characterized by broproliferation. Depending on
the balance between broproliferation and alveolar repair, some patients re-
cover without sequelae, but others experience pulmonary brosis and chronic
respiratory failure. Neutrophils become highly activated in response to in-

ammatory stimuli and they are key modulators of the magnitude of injury
during ALI and ARDS.[20]
The scenario where this phenomena takes place is represented by a \wet"
lung with alveolar instability and areas which collapse, leaving little room for
ventilation. The alveoli of the remaining \baby lung"2, which has to receive
the entire minute ventilation, will be abnormally stretched and overdistended,
2\baby lung" is that part of the lung that keeps normal aeration. The shape of this
part reminds the one of a normal lung but with smaller size; that is why it is so called
\baby lung"1.2. LUNG DISEASE 9
particularly if the tidal volume is not properly reduced.[8][2][9]
1.2.2 FDG-PET: evaluation of lung in
ammation
FDG PET imaging technique allows to quantify tissue glucose metabolism
in vivo in human; for this it could be a good investigation method also be-
cause noninvasive and accurate quantication of pulmonary in
ammation
throughout the lung could be obtained. As already mentioned neutrophilis
become highly activated during ALI and for this reason they are key modula-
tors of the magnitude of injury. They rely on anaerobic glycolysis for energy
production and consume 20-30 times more glucose when activated than the
rest. In order to avoid artifacts due to glucose metabolite FDG is preferably
used instead.
FDG is a glucose analogue used as a marker of metabolism because
it is carried into cells by the same transporter proteins as glucose. Once
there, in the presence of hexokinase, it is phosphorylated to [18F]FDG-6-
phosphate, which unlike glucose-6-phosphate cannot be further metabolized
via the Krebs cycle. In tissues with low dephosphorylase activity (such as
lung, brain, and heart), dephosphorylation has been found to be negligible for
at least 1 hour after FDG injection, therefore it is considered trapped intra-
cellularly. Understanding of the factors determining FDG uptake is crucial
for an adequate signal interpretation and for the introduction of FDG PET
to clinical use. The current concept, easy to guess, is that the FDG imaging
signal during ALI is predominantly determined by the combination of the ab-
solute number of neutrophils in the eld of view and their state of activation.
Even though, Prost et. al. [8] found in a sheep-model of alverolar lavage
that an increase in lung water can generate an additional volume of distri-
bution of FDG. This volume is not a precursor for phosphorylation and can
artifactually increase lung FDG uptake independently of lung in
ammation.
In this work we applied FDG quantication method to study lung glucose
metabolism in 5 healthy subjects and 12 patients aected with ALI/ARDS
at dierent stages.10 CHAPTER 1. CLINICAL OVERVIEWChapter 2
Data acquisition and
pre-processing
In this section we are going to explain how clinical tests have been con-
ducted and how data have been pre{processed before actual FDG metabolism
quantication.
2.1 Subjects and investigational protocol
The protocol was approved by the institution's ethical committee; in-
formed consent was obtained according to the committee's recommendations.
Patients were recruited from the general Intensive Care Unit (ICU) of HSR
university hospital.
Inclusion criteria were:
 diagnosis of ALI/ARDS, with a positive end-expiratory pressure (PEEP)
of at least 8 cm H2O, according to the 1994 European/American Con-
sensus conference , requiring mechanical ventilation
 planning by the attending physician of a thorax CT scan as part of the
patient's clinical management
Exclusion criteria were:
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 pregnancy
 age < 18 years
 impossibility of patient's transport according to the attending physician
 lung surgery in the previous four weeks to the PET exam
 oliguria ( urinary output <0.5 ml/kg/hour) or anuria
 known or suspected cancer
 history of chronic lung disease
 logistical reasons (e.g. PET/CT camera unavailable until patient had
lost eligibility criteria)
Once a patient was judged eligible for the study, the PET/CT scan was
scheduled, usually within one or two days; on the day of the study eligi-
bility was conrmed. The enteral or parenteral nutrition and any glucose-
containing infusion were stopped at 6 a.m. to ensure a fasting period of at
least 6-8 hours. In patients undergoing insulin therapy, this was stopped as
well and before transport to PET/CT facility, blood glucose was tested to
conrm a level between 80 and 140 mg/dl because altered glucose level could
aect test results. The PET/CT study being usually performed around 2
p.m. Before transport from the ICU to the PET/CT facility, arterial blood
gases and hemodynamic and respiratory parameters have been recorded.
During transport, and throughout the permanence in the PET/CT facility,
clinical care was provided by a physician and a nurse uninvolved in the study
procedures. Mechanical ventilation was provided by an ICU ventilator, and
invasive arterial blood pressure, ECG, peripheral oxygen saturation and ex-
pired CO2 were continuously monitored. Ventilatory settings, sedation, and

uid therapy were maintained constant throughout the study period, unless
clinically advised. At the end of the study, collection of the aforementioned
variables was repeated in the ICU. Finally, the 28 days and ICU outcome
(survival or death) of each patient were recorded.[2][1]2.2. IMAGE ACQUISITION 13
2.2 Image Acquisition
Along with PET, computed tomography (CT) scans were also performed
to obtain anatomical details.
It has been used a GE Discovery ST (GE Medical Systems, Milwaukee,
WI) PET/CT tomograph, with an axial eld of view of approximately 18 cm
(47 3.27-mm thick sections, separated by 0.48 mm intervals), equipped with
an 8-slice CT. The section of thorax to be imaged was selected on the scout
view just above the diaphragm. A spiral CT scan (slice thickness 3.75 mm,
no interval between slices) of the chosen section was obtained while holding
the patient apneic (by switching the ventilator to Constant Positive Airway
Pressure modality) at the same mean airway pressure as during mechanical
ventilation, to ensure the best possible cross-registration between the CT
scan and the PET acquisition to follow, performed during tidal ventilation.
The patient was then advanced to the PET detector; the tomograph ensures
the cross-registration of the same axial eld-of-view between the CT and the
PET acquisition. A bolus of 18FDG (approximately 300 MBq) was rapidly
injected intravenously, ve seconds after that the acquisition of sequential
PET frames was started with the following protocol: 12 frames lasting 10
seconds each (12frames x 10sec), 10frames x 30sec, 8frames x 300sec, 1frames
x 600sec, for a total imaging time of 57 minutes. At the end of the PET scan-
ning two additional sets of CT scans holding the airway pressure constant at
the level of end- expiration (PEEP, CTEXP) and end-inspiration (Plateau
pressure, CTINSP) were acquired to obtain images of the regional lung ex-
pansion induced by tidal ventilation.
2.3 Image Processing
Dynamic PET data were reconstructed by ordered-subset expectation
maximization (OSEM) iterative algorithm and corrected for decay, scatter,
random counts. Before quantication some operations are needed
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2. Extraction of regions of interest
3. Extraction of input function from PET images
These elaborations have been made with a software specically developed in
Matlab environment (Matlab R2009b, The Mathworks, Natick, MA).
Data needed were extracted directly from noisy PET images; in order to
obtain signal as thorough as possible, a precise ROI denition was needed.
2.3.1 Masking
Thoracic area is wide and heterogeneous so we need to dene an area
of interest to limit external contributions. We have to segment lung tissue,
to quantify glucose metabolism, and aorta area to be able to extract input
function.
Lung
Lung eld (Region of interest, ROIL) was manually outlined on the CT
images, carefully avoiding the large airways, vessels and pleural eusion.
Considering lung heterogeneity, a semi-automatic iterative algorithm has
been implemented to be able to process aerated and not aerated regions
and allow clinicians to choose lung tissue area.
First of all, a threshold value was required to discern between aerated (
threshold 0.3) and not aerated (threshold 0.05-0.1) tissue then the user has to
select a voxel on the CT image according to the threshold. The region was
then iteratively grown by comparing all unallocated neighboring voxels to
the region. The dierence between a voxel's intensity value and the region's
mean, was used as a measure of similarity. The voxel with the smallest
dierence measured this way was allocated to the respective region. This
process stopped when the intensity dierence between region mean and new
voxel become larger than the selected threshold and an image of the selected
area was shown near the CT image. The user could then decide to add other
regions or go on analyzing other slices.2.3. IMAGE PROCESSING 15
(a) Lung CT image (b) Mask of one the lung
Figure 2.1: Lung CT image in one representative subject and corresponding
mask.
Aorta
Denition of aorta mask is less precise and rely more on clinician experi-
ence. Observing PET images at early time ROI, mask was dened approx-
imately in the center of the descending aorta over few slices, selecting few
voxel showing higher activity.
Figure 2.2: PET image of one representative subject showing aorta area.
2.3.2 Density based ROI
The original CT matrix, with a size of 512-by-512 voxels, was re-scaled
to achieve the same dimension (128-by-128) and voxel size (4.5 mm) of the
original PET image. This scaling process lowers the spatial resolution of CT
to a level similar to PET. To select regions of interest we need to sub-segment16 CHAPTER 2. DATA ACQUISITION AND PRE-PROCESSING
lung tissue previously dened with masking procedure. ROIs were dened
on CT images following two congurations:
 original ROIL was sub{segmented by allocating all the voxels within
\bins" 100 Hounseld Units (HU) wide (the rst \submask" enclosed
all the voxels between -1000 HU and -900 HU, the second comprised all
the voxels between -900 HU and -800 HU, and so forth) in order to de-
scribe the intra-patient relationship between lung density and [18F]FDG
uptake.
 a segmentation ables to discern between in
amed tissue, with alveo-
lar instability collapse, and the remaining healthy one, whose alveoli
are overdistended to compensate for loss of functionality (draft on Fig-
ure 2.3). These two area (low density and high density) were dened
as follows
{ Normally Aerated (NA): [-900 -501] Hounseld Units (HU)
{ Collapsed or consolidated (CO): [-100 100] Hounseld Units (HU)
(a) Normal (b) Alveolar Flooding
(c) Alveolar Collapse
Figure 2.3: Dierent alveolar situation in ALI. The red box is an example of
voxel area.2.3. IMAGE PROCESSING 17
(a) Aerated region on CT image (b) Aerated region mask
(c) Collapsed region on CT image (d) Collapsed region mask
Figure 2.4: CT image in one representative subject and corresponding mask
of both aerated and collapsed tissue.18 CHAPTER 2. DATA ACQUISITION AND PRE-PROCESSING
2.3.3 Input function
Assessment of lung FDG kinetics implies knowledge of the time-activity
curve in pulmonary artery plasma as an input function. Acquisition of this
input function typically involves sequential arterial blood sampling, a process
that is invasive and prone to measurement artifacts, exposes the clinical sta
to radiation and blood, and adds costly laboratory procedures.
Literature provides methods to extract the input function; one of this is
the image dened input function. Some conditions are required:
 individuation of a large arterial vessel
 partial volume and spillover correction
 absence or minor presence of metabolites.
We could apply this method because we dened the input function directly
on the aorta, that is the biggest artery and limits partial volume and spillover
contributions. As regards the third condition, FDG hasn't got metabolites so
all conditions were fullled. In the current study after we had dened aorta
region, aorta activity curves were collected and one third of these (the ones
with the higher peaks) were taken into consideration to obtain the rst part
of the average blood signal (rst minute, when the signal is higher). Signal
was completed averaging the remaining two thirds of the collected curves.
Operating this way, we could obtain a plasmatic activity curve with a high
peak and a low \tail".
Tissue activity curves were easier to calculate because it was not necessary
to obtain a high and well dened peak, but it was sucient to simply average
the activity of the ROI. In some cases, it has been necessary to shift the
plasmatic curve to t time-peak with the tissue one.2.3. IMAGE PROCESSING 19
(a) Aorta activity curves in one representative
subject
(b) One-third of total curves with higher peak
(c) Resulting input function
Figure 2.5: Steps to obtain input function from aorta activity curves in one
representative subject.20 CHAPTER 2. DATA ACQUISITION AND PRE-PROCESSINGChapter 3
Modeling and physiological
parameter quantication
Positron emission tomography makes possible a non invasive measure-
ment and imaging of tracer concentration at regional level. Image analysis
can be either qualitative, quantitative with opportune mathematical models
or through visual inspection. In recent years several models and methods to
convert radioactivity concentration into physiological parameters have been
developed: compartmental (Sokolo et. al., 1977), data{driven (Cunning-
ham et al., 1993) and graphical (Patlak et. al., 1983) models.
Compartmental models are widely used in tracer kinetic studies; their
purpose is to provide a quantitative description in terms of rate of eusion,
transport and metabolism of a certain substance starting from tissue-time
and plasma activity curves.
Data{driven methods are based on a black box estimation problem de-
scription. A very popular one is the so called Spectral Analysis, introduced
by Cunningham et al. in 1993 and described in the next chapter.
Graphical methods are easy to use and for this reason are very popular
in the quantication of PET images. No particular arrangement or number
of compartments is assumed; only reversibility/irreversibility characteristics
are required.
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3.1 Patlak Method
The Patlak graphical method is a linear technique which has been widely
used in dynamic PET data quantication to obtain a quite precise parameter
that could be used as a \gold standard" for other analysis, for example to
partially validate models thereafter described. On the one hand, it doesn't
allow to estimate all kinetic parameters but only a macro one instead; on
the other, a precise knowledge of compartmental structure is not necessary.
Nevertheless some hypotheses have to be fullled:
 there must be only one irreversible compartment
 the tracer should leave reversible compartment through the irreversible
one or plasma
 the tracer kinetic should be described by linear dierential equations
of the rst order
 there should be a time T after which all reversible compartments are
equilibrated with plasma.
The Patlak plot belongs to a group of graphical analysis techniques,
whereby the measured TAC undergoes a transformation and is plotted against
some sort of \normalized time". The Patlak plot is given by the expression
Ctissue
Cp
= K
R t
0 Cp()d
Cp(t)
+ V (3.1)
This means that the measured PET activity is divided by plasma activity,
and plotted at a \normalized time" (integral of input curve from injection
divided by instantaneous plasma activity).
For systems with irreversible compartments this plot will result in a
straight line after sucient equilibration time. For the FDG model the slope
represents the net uptake rate, while the intercept V is equal to V0 + Vb with
the distribution volume V0 of the reversible compartment and the fractional3.2. COMPARTMENTAL APPROACH 23
Figure 3.1: Example of Patlak plot
blood volume Vb. K value of equation 3.1 represents the regional metabolic
glucose rate.
3.2 Compartmental Approach
Models used to quantify FDG kinetics have been developed and validated
mostly to study solid organs such as brain, heart and liver.
During ALI there is the presence of healthy and injured tissue but no specic
models for its description have been developed yet. Models already imple-
mented for solid organs are not suitable for lungs because they have greater
air content, lower basal glucose consumption, a larger perfusion to tissue ra-
tio and a larger parenchymal edema and 
ooding to tissue ratio during organ
injury.
A priori knowledge of compartmental structure is not available as well as the
number of compartments necessary to describe tissue kinetic model. Avail-
ability of PET data together with plasma samples allows to t compartmen-
tal models and obtain variable estimation related to tissue FDG transport
and uptake. The following three compartmental models with an increasing
number of compartments have been used to study pulmonary FDG kinetics24CHAPTER 3. MODELING AND PHYSIOLOGICAL PARAMETER QUANTIFICATION
during ALI.
3.2.1 Two-compartment model: Patlak
Patlak et al. ([14]) proposed a model initially conceived to estimate cere-
bral glucose utilization. The model is composed of a central compartment in
rapid equilibrium with blood plasma and a peripheral compartment in which
the radiotracer is irreversible trapped.
Figure 3.2: Generalized two-compartment (Patlak). The arrow indicates the
directions of mass transport.
The main advantages of this model are the simple application and inter-
pretation.
For what concerns lung tissue, the Patlak model has been applied by Jones
et al.[10] and Bellani et al.[2]; each study proposes a normalization for the
K constant. Jones normalized to tissue volume (Ve) to take into account the
distribution volume of FDG in lung tissue; Bellani proposed to normalize by
the mean fractional density of the lung, computed as (CTmean + 1000(/1000,
where CTmean is the average CT number of the ROI. The implication of these
normalizations are not well dened (e.g., they correct for the amount of tissue
in the ROI, but it is unknown whether to take into account the lung edema).
This uncertainty could be a limitation to the application of the Patlak model
in ALI.
3.2.2 Three-compartment model: Sokolo
Three-compartment model was originally conceived by Sokolo et al. [17]
and then used for PET [18F]FDG studies in the brain and other organs/tissue.
It shows blood and two tissue compartments, precursors and metabolic, and3.2. COMPARTMENTAL APPROACH 25
together with the input-output experiment is described by
_ Ce(t) = k1Cp(t)   (k2 + k3) Ce(0) = 0 (3.2)
_ Cm(t) = k3Ce(t) Cm(0) = 0 (3.3)
Transfer constant rates characterize the transport between compartments:
 k1 quanties facilitated FDG transport from blood into the tissue (pre-
cursors compartment) per unit of tissue volume;
 k2 quanties tracer transport from the precursor compartment back
into blood;
 k3 characterizes FDG phosphorylation to 18FDG-6-phosphate (metabolic
compartment), which is assumed to be proportional to hexokinase ac-
tivity.
Concentrations are so characterized: Cp(t), [18F]FDG plasma concentration;
Ce(t), [18F]FDG tissue concentration; Cm(t) [18F]FDG-6-P tissue concentra-
tion. There's no equation for the rst compartment Cp(t) because in PET
studies it is supposed to be known (from direct blood sampling or by extrap-
olation algorithm) and used for model identication. Blood activity curve is
used as input function in model identication
Cb(t) = Cp(t)(1   0:3  H) (3.4)
where H is subject haematocrit.
From these compartments, a global measure of the fractional uptake (K) of
[18F]FDG and the distribution volume of the precursors compartment (Fe)
as a fraction of lung volume can be computed:
K = k1  k2=(k2 + k3) (3.5)
Fe = k1=(k2 + k3) (3.6)
thus
K = Fe  k3 (3.7)26CHAPTER 3. MODELING AND PHYSIOLOGICAL PARAMETER QUANTIFICATION
that is equivalent to the one computed with the Patlak method.
Figure 3.3: Three-compartment model. Arrows indicate the directions of
mass transport.
The Sokolo model includes the assumptions that after phosphorilation
the radiotracer is irreversibly trapped into the tissue and that all extravas-
cular unmetabolized FDG in the region of interest is present in a single
compartment, immediately available for phosphorylation.
The application of the Sokolo model to lung tissue may not be completely
accurate for both healthy subjects and patients because blood-tissue FDG
exchange does not follow the same dynamic of other tissues and large pools
of edematous tissue can be functionally separated from cells trapping FDG.
Therefore another compartment model for FDG kinetics during ALI has been
developed.
3.2.3 Four-compartment model: TEC
Schroeder et al. [16] formulated a model of lung [18F]FDG kinetics that
includes an extravascular/noncellular compartment in addition to blood and
parenchyma, representing a pool of [18F]FDG that is not a direct precursor for
phosphorylation. The tracer activity is considered as the sum of activities in
four functional compartments; Cp(t) and Cm(t) are the same as the Sokolo
model (blood compartment and metabolite compartment) while, instead of
only one compartment for [18F]FDG tissue concentration, there is an addi-
tional one. Thus, it could be dened an extravascular compartment repre-
senting the concentration of [18F]FDG that constitutes the precursor pool for
phosphorylation to [18F]FDG-6-P (Cei(t)) and an extravascular/noncellular
compartment, which accounts for the concentration of [18F]FDG that is not
an immediate precursor for phosphorylation (Cee(t)).
 k1 quanties facilitated [18F]FDG transport from blood into the tissue3.2. COMPARTMENTAL APPROACH 27
 k2 quanties tracer transport from tissue back into blood
 k3 is the rate of 18FFDG phosphorylation to [18F]FDG-6-P
 k5 e k6 describe the activity concentration changes due to forward and
backward [18F]FDG transfer between the precursor compartment and
the extravascular/ noncellular compartment.
Figure 3.4: Lung-specic four-compartment model. Arrows indicate the di-
rections of mass transport.28CHAPTER 3. MODELING AND PHYSIOLOGICAL PARAMETER QUANTIFICATIONChapter 4
Spectral Analysis
Spectral Analysis is an I/O model rst implemented to determinate local
metabolic rate of glucose in the brain [18], then commonly used with various
PET tracers to study physiological systems such as liver, heart and kidney
[7] and lately applied also to lungs.
4.1 Denition
Spectral Analysis (SA) is an input-output model to identify kinetic com-
ponents of the tissue tracer activity without specic model assumptions, like
the presence or absence of homogeneity in the tissue. This technique was
introduced by Cunningham and Jones in 1993 [7] in order to determine local
metabolic rate of glucose in the brain [18], but now SA is commonly used
with various PET tracers to study physiological systems other than brain
e.g. liver, heart, kidneys, etc... ([12];[13];[11]). In SA, the measure of the
radioactivity in the tissue at the time t, Ctiss(t), is modeled as a convolution
of the plasma activity curve Cp(t) with a sum of M + 1 distinct exponential
terms:
Ctiss =
M X
j=0
Cp(t) 
 j  e
 jt (4.1)
Ctiss =
M X
j=0
j 
Z t
0
Cp()e
 j(t ) (4.2)
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where j and j (1 < 2 < ::: < M+1) are assumed positive or zero.
This constraint derives from the assumption that the SA is modelling a rst
order compartmental system. The upper limit, M+1, represents the maxi-
mum numbers of terms to be included in the model and this is, in general,
set to a large number to be established, usually 100. The values of j are
predetermined and xed in order to cover an appropriate spectral range. For
the studies in vivo involving short lived positron emitting isotopes this range
needs to extend to the slowest possible event of the tracer in the tissue up
to a value appropriate to transient phenomena (e.g. the passage of activity
through the tissue vasculature).
In general the corresponding term for limj ! 1 (i.e. j with a very
large value) is proportional to Cp(t) via j , and can be seen as a \high-
frequency" component. In the same way the corresponding term with a j
= 0 or very close is proportional to
R
Cp(t) via j and can be viewed as a
\low-frequency" component, i.e., accounting for the trapping of the tracer.
Lastly, the components corresponding to the intermediate values j (interme-
diate frequency components) will re
ect the uptake of the tracer within the
tissue with their number corresponding to the number of identiable tissue
compartments within the ROI exchanging with plasma. This number is very
important because it gives an indication of tissue heterogeneity. In light of
these particular features ut is very common to dene the SA model equation
explicitly showing the trapping in the following way
Ctiss(t) = 0 
Z t
0
C()d +
M X
j=1
j
Z t
0
Cp()e
 j(t )d (4.3)
When the s values are given beforehand, the convolution integrals in
the latter equation can be calculated using the input function. Then, the
discrete form can be expressed by the following equations:
8
> > > > <
> > > > :
Ctiss(t1) = 1  f1(1) + 2  f1(2) + ::: + M  f1(M)
Ctiss(t2) = 1  f2(1) + 2  f2(2) + ::: + M  f2(M)
. . .
Ctiss(tm) = 1  fk(1) + k  fk(2) + ::: + M  fk(M)
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where k denotes the time index and fi(j) =
R ti
0 Cp()e j(t )d. A system
can be given in a matrix form where C contains Ctiss(ti), A contains j and
M is the transfer matrix containing fi(j).
  !
C =
  !
M 
  !
A (4.5)
 value corresponding to each  can be easily obtained from equation 4.1 us-
ing the non-negative least squares method. In this study estimation operation
has been done using the lsqnonneg.m function included in Matlab (Matlab
R2009b, The Mathworks, Natick, MA) and a data weighted approach. The
weight choice doesn't depend on the estimation algorithm but on the specic
features of analyzed data. Precision of the js is obtained from the inverse
of the Fisher Information Matrix. When lim j ! 1 (i.e. betaj with a very
large value) the corresponding Ctiss term is proportional to Cp(t) via j, and
can be viewed as a \high frequency" component, i.e., accounting for the fast
passage of the tracer on the vascular space of the ROI. Contrariwise the cor-
responding term with j ! 0 is proportional to
R t
0 Cp()d via j and can be
viewed as a \low frequency" component, i.e., accounting for a (quasi)trap for
the tracer. The remaining components, corresponding to the intermediate
values j (\intermediate frequency" components) will re
ect the uptake of
tracer within the tissue with their number corresponding to the number of
distinct tissue compartments within the ROI exchanging with plasma. The
number of intermediate components is very important because can give a
clear idea of tissue heterogeneity.
4.1.1 Beta Grid denition
To implement the aforementioned model the rst step was to dene j's
grid. Several distributions have been examined in previous studies, including
linear, quadratic, logarithmic and a more common one suggested by DiSte-
fano (1981) in which the range of j, j = 1,...., M was chosen as follows. The
lower limit was 1 = ( 1
3Tf), where Tf was the end time of experiment. The
upper limit was M = ( 3
Ti) where Ti was the duration of the rst scan. The32 CHAPTER 4. SPECTRAL ANALYSIS
Figure 4.1: Example of a possible SA spectrum
spacing of the js was xed as
j =
1
j
;j = j 1

Tf
Ti
[1=(M 1)]
;j = 1;:::;M (4.6)
where M is the number of the points in the distribution. The components
for 0 = 0 and M+1 ! 1 were explicit included.
4.2 Features
SA spectra resulting from dynamic PET studies provide information
about possible system behavior and could be correlated with a compart-
mental model approach. Although there are no priori assumptions, as to
the number of components necessary to obtain optimal ts, the interpreta-
tion of  and  can lead to a denition of the best compartment model.
Since the  values are discrete, the individual components of the spectra are
generally comprised of one or two adjacent values for . The sum of the 
values within each component will subsequently be referred to as the com-4.2. FEATURES 33
bined peak height for the component. Thus, a quite well dened spectrum
is obtained, and a line-position based classication provides useful tools for
model interpretation.
High-Frequency components close to or coincident with the upper level
of the predened range, could be generated by two sources. The rst corre-
sponds to the rapid transit time of tracer in the vasculature within the ROI.
This is usually modeled as a constant blood volume term (Vb). It may be
incorporated in the general linear model but the position of high frequency
components, in contrast to those at lower frequencies, are very sensitive to
the assumed delay between the arrival of arterial blood in the tissue ROI and
in the online counter and for this reason it is better to treat the constant
term as a high frequency. A second source relate to the dispersion of blood
counts measured on Ctissue(t) relative to the \true" arterial input Cp(t) to
the tissue ROI. High frequency terms have relatively little eect on the size
and position of lower frequency components which relate to tissue retention
and the subsequent release of tracer.
Intermediate and Low Frequency re
ect the extravascular behavior of the
tracer. The sum of these components plotted against time is the unit impulse
response function of the extravascular tissue. The intercept at t=0 on the
unit impulse response is the unidirectional clearance of tracer from plasma
to tissue (given by the sum of the ), it is the product of the regional 
ow
and extraction and in some cases it is an intrinsic part of the parameters
of interest. The simplest interpretation of the number of components in
the intermediate frequency range is that it corresponds with the number of
reversible compartments of the tracer which can be discriminated in the tissue
ROI. Multiple intermediate components may indicate tissue heterogeneity.
Lowest Frequency is coincident with, or close to, the limit set by the decay
constant for the isotope and indicates the irreversible, or near irreversible
trapping of the tracer. In the irreversible case the combined peak height of
the low-frequency component gives the irreversible disposal rate constant of
the tracer in blood or plasma (K, ml sec 1 ml tissue 1), that is analogous
to the Patlak K constant. This calculation is independent of the number of
\reversible" components in the intermediate range of the spectrum.34 CHAPTER 4. SPECTRAL ANALYSIS
4.3 Limitation
General SA algorithm shows some limitations such as low reliability in
explaining data and underestimation of parameters. This is probably due
to a) the presence of noise and errors in the input function signal; b) the
trapping and the blood volume that could not be clearly detected; c) the
presence of real equilibrating components of the system. Some of these factors
may cause an uncorrected spectrum, e.g., the presence of double lines, really
low-amplitude lines, higly-shifted lines. (Figure 4.2)
These limitations reduce the SA applicability especially when the data are
particularly noisy.
(a) Example of spectrum with double
lines or really high frequency compo-
nent
(b) Example of spectrum with small
amplitude line
Figure 4.2: Examples of SA spectrum problems.
4.4 New Approach: SAIF
To overcome the limits of the traditional SA a new algorithm has been
developed by Veronese et al.[19]: the Spectral Analysis Iterative Filter.
The SAIF algorithm conserves the main characteristics of SA but it is forced
to operate the estimation of the net uptake rate constant in irreversible tracer.
For this reason it may be an alternative quantication method for FDG PET
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4.4.1 Spectral Analysis Iterative Filter
A dicult operation for spectral analysis is to separate low- frequency
equilibrating components from the trapping and also to separate high- fre-
quency equilibrating components from blood.
The rst part of SAIF consists in dening the beta grid (as in traditional
spectral analysis) and set up the beta passband [L;U] ; all components
with  2 [L;U] will be considered to be real equilibrating components of
the system. The two iterative steps are as follows:
1. Components with i lower than L are assumed to result from the
trapping components while those with i > U are shifted blood com-
ponents. The components inside the passband are subtracted from the
measured activity and the new values of the coecient of the trapping
compartment (0) and the blood volume fraction (Vb) are estimated.
2. Using the new values of 0 and Vb, the contribution of trapping and
blood components are subtracted from measured data. Using NNLS
and the grid restricted to  2 [L;U] , the set of equilibrating compo-
nents are re-estimated.
The stop criterion consists in calculating the dierence between WRSS after
the two steps; if it is less than  = 0:001 the iterative algorithm stops.
Beta Grid
The denition of beta grid should follow the general guidelines of SA
but to be more consistent with the pathology study, it has been adapted to
specic dataset.
A logarithmic distribution (base 10) with 100 elements from 0.1 to 5 has
been chosen with an additional  = 0 term.
Cut-o values
The choice of the best beta passband in a crucial step of the ltering
algorithm. Dierent cut-o values were tested for this specic study and36 CHAPTER 4. SPECTRAL ANALYSIS
after looking at dierent resulting spectra, the following values were chosen:
L = 0:05 and U = 1.
4.5 Compartmental Model and SA
In chapter 3 dierent compartmental models for the description of [18F]FDG
kinetics were illustrated. SA could be useful to dene the model describing
the tracer kinetics (Bertoldo et al. 1998 [3]); it provides information about
the possible presence of trapping and the number of model compartments but
it does not give information about how these compartments are connected to
each other. Hereunder some examples are described to show the correlation
in a simple way.
One-compartmental model
(a) A.Compartmental Model (b) A.Spectrum
(c) B.Compartmental Model (d) B.Spectrum
Figure 4.3: One-compartmental model and relative spectrum.(a)(b) without
trapping; (c)(d) presence of trapping.
In the rst model K1 and k2 (Figure 4.3) correspond respectively to the4.5. COMPARTMENTAL MODEL AND SA 37
unidirectional clearance of tracer from blood to tissue and the rate constant
for the transfer from tissue to blood. The corresponding SA spectrum shows
only one component. The equations related to the model (Figure 4.3(a)) and
the SA (Figure 4.3(a)) solutions are the following:
y(t) = K1
Z t
0
Cp  e
 k2(t )d (4.7)
y(t) = 
Z t
0
Cp  e
 (t )d (4.8)
It is noticeable the equivalence between K1 $  and k2 $ . In the second
model (Figure 4.3(c)(d)), where there is no transfer of the tracer from the
tissue to the blood, i.e. k2 = 0, the solution of the model is provided simply
by the equations
y(t) = K1
Z t
0
Cpd (4.9)
y(t) = 
Z t
0
Cpd (4.10)
This is typical when a trapping compartment is present . The corresponding
spectrum still shows only one component but it is located at  = 0 and it is
called trapping component; on the contrary, all components with  6= 0 are
called equilibrating components and are related to reversible components.
Two-compartmental model
In this example there is one more compartment which corresponds to an
additional component in the spectrum. In the rst case model and spectral
analysis solution equations are:
y(t) =
K1k3
k2 + k3
Z t
0
Cp()d +
K1k2
k2 + k3
Z t
0
Cp()  e
 (k2+k3)(t )d (4.11)
y(t) = 0
Z t
0
Cp()d + 1
Z t
0
Cp()  e
 1(t )d (4.12)
In the second case there is an additional rate constant k4 for the transfer38 CHAPTER 4. SPECTRAL ANALYSIS
(a) A.Compartmental Model (b) A.Spectrum
(c) B.Compartmental Model (d) B.Spectrum
Figure 4.4: Two-compartmental model and relative spectrum.(a)(b) presence
of trapping; (c)(d) without trapping.
of the tracer from C2 to C1 and the corresponding spectrum shows a new
equilibrating component instead of the trapping one.Chapter 5
Results
In this chapter we are going to present the main results obtained from
processing [18F]FDG data using the dierent analysis methods previously
illustrated. Data were analyzed on the level of interest: Region Of Interest
(ROI) level or voxel level.
5.1 Analysis at ROI level
Two dierent ROIs were dened according to the segmentation illustrated
in section 2.3.2: Normally Aerated tissue (NA) and Collapsed/Consolidated
tissue (CO).
Before the application of the quantication methods, ROI time-activity
curves were obtained by average voxels time-activity curve within region. An
example of this is reported in Figure 5.2.
All methods work with weighted data and weights are dened according
to wi =
q
Tscani
Ctissi . Where Tscani is the length of i-esime scan (minutes)
and Ctissi is the total activity for the PET during i-esime scan.
5.1.1 Patlak Results
Patlak graphical method was applied according to what is described in
section 3.1. The tissue time-activity curve and input function were used to
obtain the Patlak plot and linearization was achieved starting on t ' 7min.
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(a) Normally Aerated (b) Collapsed
Figure 5.1: CT images in one representative subject of two dierent ROI:
normally aerated and collapsed.
(a) Voxel activity (b) ROI acitivty
Figure 5.2: Tissue time-activity curve at voxel level and tissue level.
Individual estimate
Hereunder the K parameters obtained for the two groups of healthy sub-
jects and patients are collected.
Three dierent situations are noticeable from Figure 5.3. Healthy sub-
jects show low values for K [0.0002{0.0242 (ml/g/min)] in both normal and
collapsed tissue. In regard to patients aected with ALI/ARDS two dierent
behaviors could be distinguished; one group shows low K values for normal
tissue and high values for the in
amed one, while the other group shows high
K values for both normal and collapsed tissue. From now on patients of the5.1. ANALYSIS AT ROI LEVEL 41
former group will be indicate as coupled while patients of the second group
as uncoupled. These three dierent situations are reported in Figure 5.3.
Figure 5.3: Patlak K estimate at ROI level.
Each group of subjects is characterized by dierent percentage of NA and
CO tissue towards total tissue, in detail
Group NA tissue (%) CO tissue (%)
Healthy >99 <1
Uncoupled ' 70 ' 30
Coupled ' 80 ' 20
Statistics
Individual estimations were used to obtain mean values for each group
of patients and to apply the statistical t-test. Mean, standard deviation and42 CHAPTER 5. RESULTS
p-value (from t-test) are collected in Figure 5.4 and Table 5.1; in particular
healthy subjects were compared to coupled and uncoupled.
(a) Normally Aerated
(b) Collapsed
Figure 5.4: Mean Patlak K estimate at ROI level between subjects of each
group in NA and CO tissue.
From Figure 5.4 it is noticeable that healthy subjects provide really lower
values of K estimate than patients aected with ALI; this is the natural con-
sequence of in
ammation that implies an increase in neutrophils activation.
Compared to the previous paragraph the dierence between coupled and un-
coupled subjects is even clearer; the coupled show high activation only in
consolidated tissue, the one that should be aected by in
ammation, while
the uncoupled show indiscriminately high activation.5.1. ANALYSIS AT ROI LEVEL 43
(a) Normally Aerated
Group K mean [ml/g/min] SD [ml/g/min] p value
Healthy 0.0007 0.0004
Uncoupled 0.0161 0.0066 0.0011
Coupled 0.0030 0.0006 <0.0001
(b) Collapsed
Group K mean [ml/g/min] SD [ml/g/min] p value
Healthy 0.0003 0.0002
Uncoupled 0.0136 0.0060 0.0015
Coupled 0.0085 0.0036 0.0004
Table 5.1: Statistics of Patlak K estimates at ROI level in all the groups of
subjects. t-test between healthy VS coupled and uncoupled patients was also
performed.
5.1.2 SA Results
Spectral Analysis was applied according to what is described in section
4.1. SA was rst implemented using the standard DiStefano distribution for
the beta grid, then it was also implemented with a logarithmic distribution.
As it can be seen from Figure 5.1.2, with DiStefano distribution high fre-
quency components are more aected by Vb term and this behavior biases
also the low frequency component estimation; the logarithmic distribution
was for that selected.44 CHAPTER 5. RESULTS
(a) Healthy - DiStefano (b) Healthy - Logarithmic
(c) Coupled - DiStefano (d) Coupled - Logarithmic
(e) Uncoupled - DiStefano (f) Uncoupled - Logarithmic
Figure 5.5: Comparison of SA results of representative subjects with DiSte-
fano and Logarithmic distribution for beta grid.5.1. ANALYSIS AT ROI LEVEL 45
Model t of the data
With parameters derived from the spectral analysis (i and i) an es-
timation of the time-activity curve could be obtained. The comparison of
the model prediction time-activity curve with the major activity is useful to
check the goodness of the results. Figure 5.6- 5.8 show some t examples
for NA and CO tissue of each group. Data are well tted by the blue lines
so spectral analysis seems to have high performance but looking at the next
spectra, the situation does not seem so good. SA estimated spectra present
some problems like the presence of double lines and components with ampli-
tude very close to zero.
(a) Fit (b) Spectra
Figure 5.6: SA t and spectra at ROI level in one representative healthy
subject for NA and CO tissue.46 CHAPTER 5. RESULTS
(a) Fit (b) Spectra
Figure 5.7: SA t and spectra at ROI level in one representative uncoupled
subject for NA and CO tissue.
(a) Fit (b) Spectra
Figure 5.8: SA t and spectra at ROI level in one representative coupled
subject for NA and CO tissue.5.1. ANALYSIS AT ROI LEVEL 47
Individual estimation
K estimates obtained from SA are here reported grouped in healthy, cou-
pled and uncoupled as has been previously done with the Patlak results (Fig-
ure 5.3). Table 5.2 reports mean and standard deviation of SA K estimates
performed in each group of subjects in NA and CO tissue. Figure 5.10 shows
the correlation between the Patlak and Spectral Analysis K estimates per-
formed at ROI level.
Figure 5.9: Mean SA K estimate at ROI level between subjects of each group
in NA and CO tissue.
K estimates (Figure 5.10) have the same trend as the Patlak's and this
correlation is even clearer from the scatter plot where the regression line has
slope = 0:8653 and intercept = 0:0007.48 CHAPTER 5. RESULTS
(a) Normally Aerated
Group K mean [ml/g/min] SD [ml/g/min]
Healthy 0.0007 0.0004
Uncoupled 0.0161 0.0066
Coupled 0.0030 0.0006
(b) Collapsed
Group K mean [ml/g/min] SD [ml/g/min]
Healthy 0.0012 0.0006
Uncoupled 0.0121 0.0043
Coupled 0.0089 0.0033
Table 5.2: Statistics of SA K estimates at ROI level in all the groups of
subjects.
Figure 5.10: Scatter plot between the Patlak and SA estimate at ROI level.
The regression line represents the correlation between two methods for the
K estimation of all tissue type for all subjects.5.1. ANALYSIS AT ROI LEVEL 49
Average spectrum
The average spectrum of each group were obtained after we had man-
ually selected specic beta range. All the spectra of a specic group were
visualized in one picture, then adjacent spectra lines were grouped and the
corresponding beta range was xed. The average spectrum was obtained by
meaning s and s that relapsed in each range.
Figure 5.11: SA average spectra at ROI level of all healthy subjects.
Figure 5.12: SA average spectra at ROI level of all uncoupled subjects.50 CHAPTER 5. RESULTS
Figure 5.13: SA average spectra at ROI level of all coupled subjects.
In the examples of Figure 5.6-5.8 we had already noticed a very complex
spectra situation; the same complexity is shown in the average spectra (Fig-
ure 5.11-5.13) where there are lines barely noticeable and several other lines.
It is hard to deduce physiological relevant information from this situation;
we need to \clean up" the spectrum from redundant lines with the ltered
spectral analysis.
5.1.3 SAIF Results
Spectral Analysis Iterative Filter was applied according to what is de-
scribed in section 4.4. In order to be consistent with SA results we ap-
plied the same logarithmic beta grid; we set a  passband lter interval of
[0:05   1](min 1) according to the results of standard spectral analysis.
Fit
SAIF provides t as good as SA, moreover the quality of the resulting
spectra are better; we cleaned the spectra from the double components and
the small components due to noise. Some examples, one for each subject
group, are reported in Figure 5.14-5.16.5.1. ANALYSIS AT ROI LEVEL 51
(a) Fit (b) Spectra
Figure 5.14: SAIF t and spectra at ROI level in one representative healthy
subject for NA and CO tissue.
(a) Fit (b) Spectra
Figure 5.15: SAIF t and spectra at ROI level in one representative uncou-
pled subject for NA and CO tissue.52 CHAPTER 5. RESULTS
(a) Fit (b) Spectra
Figure 5.16: SA t and spectra at ROI level in one representative coupled
subject for NA and CO tissue.
Individual estimation
SAIF K estimate reported the same trend and subject classication of
other methods; results are consistent with the Patlak K estimate (Figure 5.18).
(a) Normally Aerated
Group K mean [ml/g/min] SD [ml/g/min]
Healthy 0.0006 0.0004
Uncoupled 0.0160 0.0060
Coupled 0.0029 0.0006
(b) Collapsed
Group K mean [ml/g/min] SD [ml/g/min]
Healthy 0.0008 0.0005
Uncoupled 0.0151 0.0075
Coupled 0.0089 0.0037
Table 5.3: Statistics of SAIF K estimates at ROI level in all the groups of
subjects.
When SAIF is compared with Patlak the correlation is better than stan-
dard SA as indicated in Figure 5.18. Here the regression line is characterized
by slope = 1:039 and intercept very close to zero.5.1. ANALYSIS AT ROI LEVEL 53
Figure 5.17: Mean SAIF K estimate at ROI level between subjects of each
group in NA and CO tissue.
Figure 5.18: Scatter plot between Patlak and SAIF estimate at ROI level.
The regression line represents the correlation between the two methods K
estimate of all tissue types of all subjects.54 CHAPTER 5. RESULTS
Average spectrum
In order to obtain the average spectrum we operated in the same way as
done for spectral analysis. For each group of subjects we visualized all the
spectra together and grouped the lines with an adjacency criterion. Beta
ranges are the same for each group: range1 = [0:01  0:4] and range2 =
[0:410:9]. The lines corresponding to  > 0:91 were not considered because
probably due to Vb eect.
Figure 5.19: SAIF average spectra at ROI level of all healthy subjects.
Figure 5.20: SAIF average spectra at ROI level of all uncoupled subjects.5.2. ANALYSIS AT VOXEL LEVEL 55
Figure 5.21: SAIF average spectra at ROI level of all coupled subjects.
All spectra have the same number of lines. There is always one line
on  = 0 that corresponds to FDG trapping; in healthy subjects it is really
small for both normally aerated and collapsed tissue. Coupled subjects shows
a little more bigger trapping line for collapsed tissue while uncoupled have
quite big lines for both tissue types. As regards the equilibrating compartment
lines, there is always a small line in the rst half of the spectrum and a bigger
one in the second half. This may be due to dierent reasons:
Hp.1 lung tissue could be described by a three-compartmental model where,
besides the trapping compartment, there are two additional equilibrat-
ing compartments: one with fast FDG exchange (line near zero) and
one with slow exchange;
Hp.2 lung tissue could be described by a two-compartmental model and the
additional third line is due to tissue heterogeneity.
More information is necessary to formulate the right hypothesis, for this
reason we operated with a more precise voxel-based analysis.
5.2 Analysis at voxel level
In the previous section we operated considering all voxels within a ROI in
order to obtain an estimation of the mean parameters that should describe56 CHAPTER 5. RESULTS
ROI's behaviors. This approach leads to rough results because does not
take into account variability inside the region. For this reason we decided
to run all the analysis voxel-by-voxel, to have a more accurate description of
what is happening in all the lung parts and eventually to value the average
parameters of a region of interest. The time-activity curve needed by the
analysis methods is now the voxel's one (still weighted with wi =
q
Tscani
Ctissi )
while we used the same ROI's specications such as beta grid, bounds etc.
5.2.1 Patlak Results
Figure 5.22: Parametric map of K estimate in one representative slice of one
representative subject.
The application of the Patlak graphical method to all voxels results on
a parametric map that shows areas with higher K values than others; these
should correspond to areas with high activity and so in
amed lung tissue.
Individual estimation
Using the parametric map we calculated the average K value within a
region of interest in order to compare the results with the ones obtained from
the ROI approach. Even if the results are not the same, this is a common
practice in PET literature to check the goodness of results. K estimate at
voxel level (Figure 5.23) shows the same trend as the ROI one (Figure 5.3)
and the distinction between coupled and uncoupled subjects is still clear.5.2. ANALYSIS AT VOXEL LEVEL 57
Figure 5.23: Mean Patlak K estimate at voxel level between subjects of each
group in NA and CO tissue.58 CHAPTER 5. RESULTS
Statistics
Estimation of mean value of each group and statistical t-test results were
obtained processing voxel's K values all together.
(a) Normally Aerated
(b) Collapsed
Figure 5.24: Mean Patlak K estimate at voxel level between subjects of each
group in NA and CO tissue.5.2. ANALYSIS AT VOXEL LEVEL 59
(a) Normally Aerated
Group K mean [ml/g/min] SD [ml/g/min] p value
Healthy 0.0010 0.0001
Uncoupled 0.0160 0.0085 0
Coupled 0.0031 0.0027 0
(b) Collapsed
Group K mean [ml/g/min] SD [ml/g/min] p value
Healthy 0.0014 0.0011
Uncoupled 0.0166 0.0102 0
Coupled 0.0098 0.0067 0
Table 5.4: Statistics of Patlak K estimates at voxel level in all the groups
of subjects. t-test between healthy VS coupled and uncoupled patients was
also performed.
5.2.2 SAIF Results
We applied only the ltered spectral analysis and not the traditional one.
With standard SA we did not obtain good results at ROI level so we foresaw
to have bad results also at voxel level because of the increased noise.
Spectral analysis iterative lter was applied with the same beta grid and
beta passband as the ROI approach. For each voxel we obtained a dierent
spectrum and so a specic K estimate and a specic data t.
Model t of the data
Hereunder are collected some examples of SAIF spectra and respective
data t of two representative voxels (one for each tissue type) for every
subject group.60 CHAPTER 5. RESULTS
(a) Fit (b) Spectra
Figure 5.25: SAIF t and spectra at voxel level in one representative healthy
subject for NA and CO tissue.
(a) Fit (b) Spectra
Figure 5.26: SAIF t and spectra at voxel level in one representative uncou-
pled subject for NA and CO tissue.5.2. ANALYSIS AT VOXEL LEVEL 61
(a) Fit (b) Spectra
Figure 5.27: SAIF t and spectra at voxel level in one representative coupled
subject for NA and CO tissue.
The quality of the t is consistent with the high level of noise of the data.
In contrast with the ROI activity curve (Figure 5.14- 5.16), the voxel time-
activity curves seem to be really noisy, particularly at early time. Spectra
mostly show a three components behavior even though the rst equilibrating
component line is often really close to the trapping one or, as in healthy case,
hasn't got a signicant amplitude.
Individual estimation
Individual estimation for each subject was achieved by working out an
average of voxel's K value; the new Ksubject were then used to calculate the
global Kmean of each group.62 CHAPTER 5. RESULTS
Figure 5.28: Mean SAIF K estimate at voxel level between subjects of each
group in NA and CO tissue.
(a) Normally Aerated
Group K mean [ml/g/min] SD [ml/g/min]
Healthy 0.0006 0.0004
Uncoupled 0.0160 0.0060
Coupled 0.0029 0.0006
(b) Collapsed
Group K mean [ml/g/min] SD [ml/g/min]
Healthy 0.0008 0.0005
Uncoupled 0.0151 0.0075
Coupled 0.0089 0.0037
Table 5.5: Statistics of SAIF K estimates at voxel level in all the groups of
subjects.5.2. ANALYSIS AT VOXEL LEVEL 63
Figure 5.29: Scatter plot between Patlak and SAIF estimate at voxel level.
The regression line represents the correlation between the two methods K
estimate of all tissue types of all subjects.
Figure 5.29 shows a good correlation between the Patlak and SAIF voxel
results. Then we dened 12 dierent regions on CT density basis and cal-
culated each Kmean (Figure 5.30- 5.31). We can notice a good Patlak and
SAIF correlation at detailed level as well as the more general NA and CO
classication.
Figure 5.30: Patlak K estimate for coupled and uncoupled patients in 12
dierent density regions.64 CHAPTER 5. RESULTS
Figure 5.31: SAIF K estimate for coupled and uncoupled patients in 12
dierent density regions.
Components statistics
Since visual inspection of all voxels spectra would have taken too much
time, we used an automated procedure to count spectrum lines and tried to
prise out tissue model complexity. Figure 5.33 gives us important information
about probable tissue kinetic model. Looking at the rst two bar groups it
is noticeable that only 20% of the total lung tissue has a spectrum with two
equilibrating components while the majority shows a simpler model with
only one component. If we go into detail we can notice the same trend for
both aerated and collapsed tissue. This is why we think that the spectrum
increased complexity is not due to an eective increase in the tissue model
complexity but to tissue heterogeneity.
From Figure 5.34 we can perceive that voxels characterized by only one
equilibrating component (that are about 80% of the total) have this compo-
nent at low frequency while, voxels with two equilibrating components (about
20% of the total) do not show a specic pattern of distribution.5.2. ANALYSIS AT VOXEL LEVEL 65
Figure 5.32: Parametric map of Patlak-K and SAIF-K estimate in one rep-
resentative slice of one representative subject.66 CHAPTER 5. RESULTS
Figure 5.33: SAIF detected components incidence in dierent tissues. 1C
refers to one equilibrating component; 2C refers to two equilibrating compo-
nents.5.2. ANALYSIS AT VOXEL LEVEL 67
Figure 5.34: Distribution of SAIF voxel components at low and high fre-
quency. 1L refers to one low component; 1H refers to one high component;
2L refers to two low components; 1L/1H refers to one low and one high
components.68 CHAPTER 5. RESULTS
Spectrum examples
Figure 5.35 collects some spectrum examples of all possible situations.
Each line refers to a dierent group of subjects: (a)(d) healthy; (e)(h) un-
coupled; (i)(l) coupled. Every line shows, in order, two spectra for NA tissue
(the rst with only one component and the second with two components)
and two spectra for CO tissue.5.2. ANALYSIS AT VOXEL LEVEL 69
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These examples strengthen the idea that there is a large heterogeneity
among subjects and NA and CO tissue.
5.3 ROI vs Voxel
The results obtained from ROI-based and voxel-based analysis are con-
sistent as regards K estimations whereas are not for spectrum constitution.
The following pictures show the correlation between ROI and voxel analysis
for each method.
Patlak
(a) K values (b) Correlation ROI-Voxel
Figure 5.36: Correlation of Patlak-K estimates obtained from ROI and voxel
analyses5.3. ROI VS VOXEL 71
SAIF
(a) K values (b) Correlation ROI-Voxel
Figure 5.37: Correlation of SAIF-K estimates obtained from ROI and voxel
analyses
The advantage of a voxel-by-voxel analysis is to investigate tissue hetero-
geneity that still does not aect ROI mean estimates; this can be seen from
the good correlations of Figure 5.36{5.37.72 CHAPTER 5. RESULTSChapter 6
Conclusion
In this work we applied the traditional [18F]FFDG PET quantication
methods to patients aected with ALI. We rst applied the Patlak graphical
method, the Spectral Analysis and the Spectral Analysis Iterative Filter to
two dierent regions of interest and thereafter to all voxels individually. The
aim of the study was to verify the applicability of traditional PET quan-
tication methods to lung tissue, not merely to solid organs, and to obtain
physiological relevant information about the in
ammation mechanism.
At the beginning we had to dene the regions of interest and this was
achieved through CT segmentation on the basis of considerations about the
tissue density. Low CT density is characterized by normal alveolar disten-
tion typical of healthy and aerated tissues while high density tissues can show
two dierent congurations: alveolar collapse typical of hypoxemia or normal
alveolar distention with presence of tissue edema.
The Aapplication of the Patlak method to normally aerated and collapsed
lung tissue, gave us important information about FDG tissue uptake. Healthy
subjects showed low FDG uptake equally, while two dierent patterns were
recognizable within patient group. A group of 7 patients showed higher up-
take for collapsed tissue than the normally aerated while the remaining 5
patients showed high value of FDG uptake in both kinds of tissue. This was
probably due to the presence of alveolar edema but more information was
necessary to formulate a denitive hypothesis. In order to obtain hints about
7374 CHAPTER 6. CONCLUSION
kinetic description, we applied both spectral analysis and its ltered version
but the latter provided better results so it was preferable.
We noticed that the estimation of SAIF parameters describing FDG uptake
was well correlated with the Patlak results corroborating trustworthiness
of subsequent SAIF estimations. This correlation was strengthened by the
voxel-by-voxel analysis so we can conclude that the Patlak and SAIF meth-
ods can be successfully applied to solid organs and lung tissue as well.
Looking at SAIF spectra obtained by means of ROI analysis we could conjec-
ture that FDG kinetic in lung tissue was described by a three compartmental
model, however a second hypothesis could be made, i.e. spectra complexity
was due to heterogeneity and so the actual model had just two compart-
ments. The results obtained by the application of SAIF at voxel level seem
to conrm the second hypothesis. Tissue heterogeneity does not seem to
aect mean FDG uptake quantication, in fact, K estimates obtained with
the ROI and voxel approach, correlate very well to each other.
In conclusion we can say that ALI patients have not homogeneous behavior,
some of them show pathological characteristics in normally aerated tissues,
and that is probably caused by dierences in pathology seriousness. We can
not propose a denitive model describing FDG kinetic in lung tissue; in fact,
at ROI level a three compartmental one seems to be correct while the voxel
analysis seems to prove the existence of a two compartment behavior. This
dierence could be due to tissue heterogeneity but further investigations are
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